GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.0135 $0.0135 Friday, 5th Apr 2024 ATHX stock ended at $0.0135. During the day the stock fluctuated 0% from a day low at $0.0135 to a day high of $0.0135.
90 days $0.0116 $0.0212
52 weeks $0.0116 $1.14

Historical Athersys prices

Date Open High Low Close Volume
2023-10-05 $0.427 $0.440 $0.299 $0.329 979 786
2023-10-04 $0.438 $0.460 $0.400 $0.440 266 279
2023-10-03 $0.442 $0.450 $0.396 $0.438 189 568
2023-10-02 $0.435 $0.440 $0.404 $0.421 420 053
2023-09-29 $0.450 $0.450 $0.376 $0.432 839 028
2023-09-28 $0.344 $0.362 $0.320 $0.358 181 399
2023-09-27 $0.350 $0.359 $0.311 $0.327 267 834
2023-09-26 $0.315 $0.355 $0.290 $0.332 570 649
2023-09-25 $0.320 $0.320 $0.290 $0.302 83 921
2023-09-22 $0.282 $0.310 $0.282 $0.291 223 625
2023-09-21 $0.302 $0.331 $0.280 $0.282 229 842
2023-09-20 $0.321 $0.340 $0.303 $0.303 152 188
2023-09-19 $0.317 $0.334 $0.303 $0.311 384 787
2023-09-18 $0.320 $0.350 $0.303 $0.312 765 431
2023-09-15 $0.462 $0.476 $0.300 $0.300 629 609
2023-09-14 $0.424 $0.444 $0.424 $0.430 94 116
2023-09-13 $0.447 $0.450 $0.424 $0.424 91 445
2023-09-12 $0.450 $0.456 $0.415 $0.456 108 730
2023-09-11 $0.460 $0.490 $0.431 $0.435 240 365
2023-09-08 $0.450 $0.452 $0.407 $0.452 184 415
2023-09-07 $0.432 $0.460 $0.410 $0.444 142 343
2023-09-06 $0.476 $0.478 $0.440 $0.442 275 462
2023-09-05 $0.560 $0.560 $0.440 $0.476 422 129
2023-09-01 $0.473 $0.480 $0.450 $0.470 280 398
2023-08-31 $0.485 $0.488 $0.458 $0.488 208 567
Click to get the best stock tips daily for free!

About Athersys

Athersys Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study f... ATHX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT